Delpor

About

Delpor is a biotechnology company developing drug delivery technologies to transport proteins, peptides, and small molecules.

San Francisco,California,United States
1 - 10

Highlights

Details

Last Funding Type: Grant
Last Funding Money Raised: $2.50M
Industries: Biopharma,Biotechnology,Commercial
Founded date: Jan 1, 2009
Number Of Employee: 1 - 10
Operating Status: Active

Delpor, Inc. engages in developing and acquiring drug delivery technologies that enable the sustained or pattern specific release of proteins, peptides, and small molecules through a small non-mechanical subcutaneous implant. Its technologies include Prozor, which is used for the delivery of antipsychotics and other small molecule drugs from a non-mechanical implantable drug delivery device; NANOPOR, a non-mechanical implantable drug delivery device in which sustained release is provided by membrane architecture; and Delos PUMP, a self-contained and electro-osmotically driven implantable drug delivery device to deliver drugs in predetermined patterns. The company was incorporated in 2009 and is based in San Francisco, California.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

4

$4.87M

Delpor has raised a total of $4.87M in funding over 2 rounds. Their latest funding was raised on Nov 16, 2021 from a Grant round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Nov 16, 2021	Grant	$2.50M	1	National Institutes of Health	—	Detail
Mar 28, 2016	Series A	$1M	1	—	—	Detail
Oct 3, 2013	Debt Financing	$470K	—	—	—	Detail
Jun 16, 2010	Series Unknown	$0.90M	—	—	—	Detail